Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | -- |
| Cost of Revenue | -- | -- | -- | 1.00K | -- |
| Gross Profit | -- | -- | -- | -1.00K | -- |
| SG&A Expenses | 421.30K | 408.80K | 420.70K | 837.60K | 609.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 421.30K | 408.80K | 420.70K | 838.60K | 609.80K |
| Operating Income | -421.30K | -408.80K | -420.70K | -838.60K | -609.80K |
| Income Before Tax | -495.80K | 820.40K | -2.09M | -1.49M | -2.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -495.80K | 820.40K | -2.09M | -1.49M | -2.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -495.80K | 820.40K | -2.09M | -1.49M | -2.28M |
| EBIT | -421.30K | -408.80K | -420.70K | -838.60K | -609.80K |
| EBITDA | -419.60K | -407.20K | -419.10K | -834.40K | -605.70K |
| EPS Basic | -0.73 | 1.30 | -3.38 | -3.74 | -8.04 |
| Normalized Basic EPS | -0.47 | -0.48 | -0.58 | -1.10 | -2.28 |
| EPS Diluted | -0.73 | 0.77 | -3.38 | -3.74 | -8.04 |
| Normalized Diluted EPS | -0.47 | -0.28 | -0.58 | -1.10 | -2.28 |
| Average Basic Shares Outstanding | 682.20K | 631.20K | 618.90K | 399.70K | 283.60K |
| Average Diluted Shares Outstanding | 682.20K | 1.07M | 618.90K | 399.70K | 283.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |